CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, AND SULFUR

CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, AND SULFUR was reported 474 times

CANDIDA ALBICANS, WOOD CREOSOTE, SODIUM CHLORIDE, AND SULFUR is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 URINARY TRACT POLYP 1 0.1250
1 CARDIAC PACEMAKER ADJUSTMENT 1 0.0370
2 SINUPLASTY 1 0.0278
3 SALIVARY GLAND MUCOCOELE 1 0.0227
4 NAIL PICKING 1 0.0222
5 GENITAL ODOUR 1 0.0169
6 LIP INFECTION 2 0.0094
7 INCARCERATED INGUINAL HERNIA 1 0.0082
8 BACTERIA BLOOD IDENTIFIED 1 0.0076
9 RENAL CYST INFECTION 1 0.0063
10 ASTROCYTOMA, LOW GRADE 1 0.0059
11 LARYNGEAL INJURY 1 0.0058
12 ELECTIVE SURGERY 1 0.0054
13 CYSTITIS RADIATION 1 0.0052
14 CATHETER SITE VESICLES 1 0.0051
15 BAND NEUTROPHIL COUNT INCREASED 1 0.0051
16 POSTOPERATIVE DELIRIUM 1 0.0051
17 HYPOCHROMASIA 1 0.0050
18 VAGINAL LACERATION 1 0.0046
19 URINARY TRACT DISCOMFORT 2 0.0043
20 BLADDER MASS 2 0.0040
21 FACIAL WASTING 1 0.0037
22 POIKILOCYTOSIS 1 0.0036
23 PENILE DISCHARGE 1 0.0036
24 ORTHOSIS USER 1 0.0036
25 BACTERIAL VULVOVAGINITIS 1 0.0035
26 POLYCHROMASIA 1 0.0033
27 ELECTROCARDIOGRAM QT SHORTENED 1 0.0033
28 FEMALE ORGASMIC DISORDER 1 0.0030
29 LICHEN SCLEROSUS 2 0.0029
30 CYSTITIS ESCHERICHIA 1 0.0028
31 LOWER URINARY TRACT SYMPTOMS 1 0.0028
32 PERIODIC LIMB MOVEMENT DISORDER 1 0.0027
33 NEUROSARCOIDOSIS 1 0.0027
34 ADMINISTRATION SITE REACTION 1 0.0026
35 COVID-19 IMMUNISATION 2 0.0024
36 OCULAR NEOPLASM 1 0.0021
37 ABORTION THREATENED 1 0.0020
38 TRANSURETHRAL PROSTATECTOMY 1 0.0020
39 HERPES ZOSTER OTICUS 1 0.0020
40 LEFT VENTRICULAR DILATATION 1 0.0020
41 BLADDER OBSTRUCTION 1 0.0019
42 DEVICE USE CONFUSION 1 0.0019
43 SCIATIC NERVE NEUROPATHY 1 0.0019
44 HYPERTENSIVE URGENCY 1 0.0018
45 URINARY TRACT INFECTION FUNGAL 1 0.0017
46 NERVE BLOCK 1 0.0017
47 BLADDER DISCOMFORT 2 0.0016
48 SEROMA 2 0.0016
49 BLADDER IRRITATION 1 0.0016
50 THYROXINE INCREASED 1 0.0014
51 NONINFECTIVE ENCEPHALITIS 1 0.0014
52 DISSOCIATIVE DISORDER 1 0.0014
53 DELUSIONAL DISORDER, UNSPECIFIED TYPE 1 0.0013
54 CATHETER SITE RELATED REACTION 1 0.0013
55 MONOCLONAL IMMUNOGLOBULIN PRESENT 1 0.0013
56 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 1 0.0013
57 RETINAL PIGMENTATION 1 0.0013
58 VACCINATION COMPLICATION 1 0.0012
59 VULVOVAGINAL ERYTHEMA 1 0.0012
60 APTYALISM 1 0.0012
61 VITAL FUNCTIONS ABNORMAL 1 0.0012
62 DRUG LEVEL FLUCTUATING 1 0.0011
63 MUSCLE SWELLING 1 0.0011
64 METAMORPHOPSIA 2 0.0011
65 BUNDLE BRANCH BLOCK 1 0.0011
66 SKIN TEXTURE ABNORMAL 1 0.0010
67 BLADDER CATHETERISATION 1 0.0010
68 BLOOD IRON ABNORMAL 1 0.0010
69 IDIOSYNCRATIC DRUG REACTION 1 0.0010
70 JOINT CREPITATION 2 0.0010
71 GASTRIC PH DECREASED 1 0.0010
72 INFUSION SITE DISCOMFORT 1 0.0010
73 BONE NEOPLASM 1 0.0009
74 ACARODERMATITIS 1 0.0009
75 OCULAR TOXICITY 1 0.0009
76 CATHETER RELATED COMPLICATION 1 0.0009
77 SARCOMA 1 0.0009
78 METHAEMOGLOBINAEMIA 2 0.0009
79 RADIATION SKIN INJURY 1 0.0009
80 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
81 BLADDER OPERATION 1 0.0009
82 SMALL INTESTINAL RESECTION 1 0.0009
83 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
84 PROSTATIC OPERATION 1 0.0008
85 STAPHYLOCOCCAL SKIN INFECTION 1 0.0008
86 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
87 VULVOVAGINAL PRURITUS 4 0.0008
88 DYSURIA 28 0.0008
89 IMPLANTABLE DEFIBRILLATOR INSERTION 1 0.0008
90 ACROCHORDON 1 0.0008
91 LIP EXFOLIATION 1 0.0008
92 CYSTITIS NONINFECTIVE 1 0.0007
93 CHONDROPATHY 2 0.0007
94 CATAPLEXY 1 0.0007
95 VASCULAR INJURY 1 0.0007
96 HYPERTONIC BLADDER 2 0.0007
97 NONINFECTIVE GINGIVITIS 1 0.0007
98 SLEEP PARALYSIS 1 0.0007
99 URINE ODOUR ABNORMAL 4 0.0007
100 COCCYDYNIA 1 0.0007
101 INFUSION SITE INDURATION 1 0.0007
102 PROSTATITIS 2 0.0007
103 CALCULUS URINARY 1 0.0006
104 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
105 BLADDER PAIN 2 0.0006
106 CYSTITIS INTERSTITIAL 1 0.0006
107 OROPHARYNGEAL BLISTERING 1 0.0006
108 INTESTINAL POLYP 1 0.0006
109 SPINAL CORD DISORDER 1 0.0006
110 BLOOD CALCIUM ABNORMAL 1 0.0006
111 SPINAL DEFORMITY 1 0.0006
112 BILIARY DYSKINESIA 1 0.0006
113 SLEEP TALKING 1 0.0006
114 SERUM FERRITIN DECREASED 1 0.0006
115 MICTURITION DISORDER 2 0.0006
116 MASTECTOMY 1 0.0006
117 BURNS SECOND DEGREE 1 0.0006
118 TERMINAL INSOMNIA 1 0.0006
119 VOCAL CORD PARALYSIS 1 0.0006
120 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
121 VULVOVAGINAL SWELLING 1 0.0005
122 THROMBOCYTOSIS 2 0.0005
123 PNEUMONIA KLEBSIELLA 1 0.0005
124 INJECTION SITE CELLULITIS 1 0.0005
125 BLADDER SPASM 1 0.0005
126 NARCOLEPSY 1 0.0005
127 PERONEAL NERVE PALSY 3 0.0005
128 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
129 PURULENCE 1 0.0005
130 HYPOGLYCAEMIC UNCONSCIOUSNESS 1 0.0005
131 VAGINAL DISCHARGE 5 0.0005
132 VULVOVAGINAL BURNING SENSATION 3 0.0005
133 CHROMATURIA 11 0.0005
134 RENAL MASS 1 0.0005
135 NEUROGENIC BLADDER 1 0.0005
136 OCULAR ICTERUS 2 0.0005
137 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
138 DYSPHEMIA 2 0.0005
139 INFECTIOUS MONONUCLEOSIS 1 0.0004
140 CYSTITIS 14 0.0004
141 PERIARTHRITIS 1 0.0004
142 NEPHROGENIC ANAEMIA 2 0.0004
143 VAGINAL INFECTION 2 0.0004
144 PRURITUS GENITAL 1 0.0004
145 URINARY TRACT OBSTRUCTION 1 0.0004
146 BLOOD URINE PRESENT 8 0.0004
147 EOSINOPHIL COUNT DECREASED 1 0.0004
148 SINUS OPERATION 1 0.0004
149 URINE FLOW DECREASED 1 0.0004
150 RASH VESICULAR 2 0.0004
151 HAEMATOLOGICAL INFECTION 1 0.0004
152 FEELING DRUNK 3 0.0004
153 CATHETER SITE HAEMORRHAGE 1 0.0004
154 HYPERPARATHYROIDISM SECONDARY 1 0.0004
155 BREAST TENDERNESS 3 0.0004
156 PLATELET DISORDER 1 0.0004
157 URINARY TRACT INFECTION BACTERIAL 1 0.0004
158 HAEMORRHAGE URINARY TRACT 1 0.0004
159 ANGLE CLOSURE GLAUCOMA 1 0.0004
160 PHYSICAL DECONDITIONING 1 0.0004
161 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
162 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
163 BLOOD LACTIC ACID INCREASED 2 0.0004
164 BREAST SWELLING 1 0.0004
165 SHOULDER ARTHROPLASTY 1 0.0004
166 EAR CONGESTION 1 0.0004
167 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
168 CLUMSINESS 1 0.0004
169 RED BLOOD CELL COUNT INCREASED 1 0.0004
170 HEART RATE ABNORMAL 2 0.0004
171 TRICHORRHEXIS 1 0.0004
172 CEREBRAL THROMBOSIS 1 0.0004
173 BREAST CANCER STAGE IV 1 0.0004
174 MICTURITION URGENCY 4 0.0003
175 PHARYNGEAL DISORDER 1 0.0003
176 VITAMIN B12 DECREASED 1 0.0003
177 CREPITATIONS 1 0.0003
178 HYPOAESTHESIA ORAL 5 0.0003
179 EMERGENCY CARE 1 0.0003
180 URINARY RETENTION 11 0.0003
181 EYE INJURY 1 0.0003
182 PRE-EXISTING CONDITION IMPROVED 2 0.0003
183 FOREIGN BODY IN THROAT 1 0.0003
184 DRUG EFFECT INCREASED 1 0.0003
185 TESTICULAR PAIN 1 0.0003
186 LOOSE TOOTH 1 0.0003
187 VULVOVAGINAL DRYNESS 1 0.0003
188 HAEMORRHOIDS 6 0.0003
189 INFUSION SITE HAEMORRHAGE 1 0.0003
190 BREAST MASS 2 0.0003
191 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
192 REGURGITATION 1 0.0003
193 TEMPERATURE INTOLERANCE 3 0.0003
194 WEIGHT FLUCTUATION 3 0.0003
195 NECROTISING FASCIITIS 1 0.0003
196 RENAL PAIN 3 0.0003
197 SKIN WEEPING 1 0.0003
198 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
199 VENTRICULAR ARRHYTHMIA 1 0.0003
200 URINARY INCONTINENCE 8 0.0003
201 IMPULSIVE BEHAVIOUR 1 0.0003
202 CHRONIC SINUSITIS 1 0.0003
203 POLLAKIURIA 11 0.0003
204 BOWEL MOVEMENT IRREGULARITY 2 0.0003
205 ERUCTATION 5 0.0003
206 REHABILITATION THERAPY 1 0.0003
207 URINARY TRACT INFECTION 44 0.0003
208 TESTIS CANCER 1 0.0003
209 KIDNEY INFECTION 5 0.0003
210 PROSTATOMEGALY 1 0.0003
211 COVID-19 PNEUMONIA 3 0.0003
212 DRUG SCREEN POSITIVE 2 0.0003
213 OBSTRUCTION 1 0.0003
214 SKIN PAPILLOMA 1 0.0002
215 NOCTURIA 3 0.0002
216 TRIGGER FINGER 1 0.0002
217 GOITRE 1 0.0002
218 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
219 SLEEP TERROR 1 0.0002
220 ESCHERICHIA URINARY TRACT INFECTION 1 0.0002
221 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
222 SHOULDER OPERATION 1 0.0002
223 METASTATIC NEOPLASM 1 0.0002
224 HEPATIC LESION 1 0.0002
225 HORDEOLUM 1 0.0002
226 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
227 TONGUE DISCOLOURATION 1 0.0002
228 HAEMORRHAGIC ANAEMIA 1 0.0002
229 GRIP STRENGTH DECREASED 2 0.0002
230 PRODUCT COMMUNICATION ISSUE 2 0.0002
231 GINGIVAL SWELLING 1 0.0002
232 DYSMENORRHOEA 3 0.0002
233 VULVOVAGINAL DISCOMFORT 1 0.0002
234 WHEELCHAIR USER 1 0.0002
235 URINARY TRACT DISORDER 1 0.0002
236 HEAD INJURY 7 0.0002
237 VASCULAR DEVICE INFECTION 1 0.0002
238 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
239 URINE ABNORMALITY 1 0.0002
240 PERFORMANCE STATUS DECREASED 1 0.0002
241 UMBILICAL HERNIA 1 0.0002
242 PHOTOPHOBIA 4 0.0002
243 LACERATION 2 0.0002
244 SKIN ABRASION 1 0.0002
245 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
246 TUMOUR MARKER INCREASED 1 0.0002
247 VULVOVAGINAL PAIN 1 0.0002
248 VAGINAL HAEMORRHAGE 9 0.0002
249 HORMONE LEVEL ABNORMAL 1 0.0002
250 INCORRECT DOSAGE ADMINISTERED 1 0.0002
251 HAEMATURIA 7 0.0002
252 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
253 BLADDER DISORDER 2 0.0002
254 INABILITY TO AFFORD MEDICATION 2 0.0002
255 OVARIAN CYST 2 0.0002
256 FLUID INTAKE REDUCED 1 0.0002
257 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
258 SUBARACHNOID HAEMORRHAGE 2 0.0002
259 NEPHROLITHIASIS 9 0.0002
260 CATATONIA 1 0.0002
261 PNEUMOTHORAX 3 0.0002
262 ANORECTAL DISCOMFORT 1 0.0002
263 RETCHING 4 0.0002
264 BODY HEIGHT DECREASED 2 0.0002
265 OVERWEIGHT 1 0.0002
266 BRUXISM 1 0.0002
267 ASTHENOPIA 1 0.0002
268 GASTRIC ULCER HAEMORRHAGE 1 0.0002
269 FUNGAL INFECTION 6 0.0002
270 OCULAR DISCOMFORT 2 0.0002
271 EYE INFECTION 2 0.0002
272 FLATULENCE 10 0.0002
273 IMPAIRED DRIVING ABILITY 2 0.0002
274 GASTRIC HAEMORRHAGE 2 0.0002
275 SKIN ATROPHY 1 0.0002
276 DYSSTASIA 5 0.0002
277 HYPOVOLAEMIA 1 0.0002
278 ENERGY INCREASED 1 0.0002
279 BLOOD IRON DECREASED 2 0.0002
280 PLEURISY 1 0.0002
281 ACCIDENT 2 0.0002
282 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
283 TENDON RUPTURE 2 0.0002
284 SCOLIOSIS 1 0.0002
285 HOT FLUSH 12 0.0002
286 BLOOD SODIUM DECREASED 3 0.0002
287 MUSCLE ATROPHY 2 0.0002
288 FOREIGN BODY SENSATION IN EYES 1 0.0002
289 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
290 ENTERITIS 1 0.0002
291 INFUSION SITE PAIN 2 0.0002
292 EAR PAIN 3 0.0002
293 TENDON DISORDER 1 0.0002
294 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
295 BRADYPHRENIA 1 0.0002
296 SOMNAMBULISM 1 0.0002
297 ASPERGILLUS INFECTION 1 0.0002
298 DYSGRAPHIA 1 0.0002
299 WALKING AID USER 1 0.0002
300 SINUS DISORDER 3 0.0002
301 EYE HAEMORRHAGE 2 0.0001
302 CHOLECYSTITIS CHRONIC 1 0.0001
303 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
304 FULL BLOOD COUNT DECREASED 3 0.0001
305 FEEDING DISORDER 3 0.0001
306 LYMPHOEDEMA 1 0.0001
307 HAIR GROWTH ABNORMAL 1 0.0001
308 LARGE INTESTINE POLYP 1 0.0001
309 LARGE INTESTINE PERFORATION 1 0.0001
310 BLOOD PRESSURE INCREASED 22 0.0001
311 FEELING COLD 4 0.0001
312 THERMAL BURN 1 0.0001
313 JOINT INJURY 3 0.0001
314 HYPERSOMNIA 4 0.0001
315 PANIC REACTION 1 0.0001
316 HYPOKINESIA 2 0.0001
317 FAECES SOFT 1 0.0001
318 INTENTIONAL UNDERDOSE 1 0.0001
319 APPLICATION SITE PAIN 3 0.0001
320 BLINDNESS TRANSIENT 1 0.0001
321 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
322 PULMONARY MASS 2 0.0001
323 ORAL PAIN 3 0.0001
324 HYDRONEPHROSIS 1 0.0001
325 TENDON PAIN 1 0.0001
326 AORTIC ANEURYSM 1 0.0001
327 INSURANCE ISSUE 2 0.0001
328 ANKLE FRACTURE 2 0.0001
329 BASAL CELL CARCINOMA 2 0.0001
330 BRAIN FOG 2 0.0001
331 RESPIRATORY TRACT CONGESTION 2 0.0001
332 GINGIVAL PAIN 1 0.0001
333 SENSORY LOSS 1 0.0001
334 NIGHT SWEATS 4 0.0001
335 STENT PLACEMENT 1 0.0001
336 MYASTHENIA GRAVIS 1 0.0001
337 CONSTIPATION 27 0.0001
338 FRUSTRATION TOLERANCE DECREASED 1 0.0001
339 DECUBITUS ULCER 1 0.0001
340 POLYURIA 1 0.0001
341 ABNORMAL FAECES 1 0.0001
342 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1 0.0001
343 MENSTRUAL DISORDER 1 0.0001
344 SECOND PRIMARY MALIGNANCY 1 0.0001
345 LIP SWELLING 4 0.0001
346 SENSATION OF FOREIGN BODY 1 0.0001
347 INADEQUATE ANALGESIA 1 0.0001
348 VITAMIN D DECREASED 1 0.0001
349 CARDIAC OPERATION 1 0.0001
350 ANURIA 1 0.0001
351 HYSTERECTOMY 1 0.0001
352 INTENTIONAL PRODUCT MISUSE 10 0.0001
353 BURNING SENSATION 8 0.0001
354 GROIN PAIN 1 0.0001
355 SLEEP DISORDER 8 0.0001
356 LUNG INFILTRATION 1 0.0001
357 RESPIRATORY RATE INCREASED 1 0.0001
358 GALLBLADDER DISORDER 2 0.0001
359 THIRST 2 0.0001
360 DYSPEPSIA 11 0.0001
361 GOUT 2 0.0001
362 ANAL INCONTINENCE 1 0.0001
363 HEAVY MENSTRUAL BLEEDING 1 0.0001
364 OROPHARYNGEAL DISCOMFORT 1 0.0001
365 LIP DRY 1 0.0001
366 SKIN LESION 3 0.0001
367 INCREASED TENDENCY TO BRUISE 1 0.0001
368 OVARIAN CANCER 1 0.0001
369 UROSEPSIS 1 0.0001
370 PRODUCT DISTRIBUTION ISSUE 1 0.0001
371 THINKING ABNORMAL 2 0.0001
372 SINUSITIS 11 0.0001
373 MIDDLE INSOMNIA 2 0.0001
374 FLANK PAIN 1 0.0001
375 ARTERIOSCLEROSIS 1 0.0001
376 SQUAMOUS CELL CARCINOMA 1 0.0001
377 INTESTINAL OBSTRUCTION 4 0.0001
378 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
379 OCULAR HYPERAEMIA 5 0.0001
380 RED BLOOD CELL COUNT DECREASED 3 0.0001
381 EYE INFLAMMATION 1 0.0001
382 ANGINA PECTORIS 3 0.0001
383 SUPRAVENTRICULAR TACHYCARDIA 1 0.0001
384 VITREOUS FLOATERS 1 0.0001
385 THERAPY CHANGE 1 0.0001
386 LABORATORY TEST ABNORMAL 3 0.0001
387 LIGAMENT SPRAIN 1 0.0001
388 HAEMATOCRIT DECREASED 2 0.0001
389 BLOOD PRESSURE ABNORMAL 2 0.0001
390 SALIVARY HYPERSECRETION 1 0.0001
391 BRAIN INJURY 1 0.0001
392 DYSKINESIA 4 0.0001
393 DRY THROAT 1 0.0001
394 NEUTROPHIL COUNT INCREASED 1 0.0001
395 THERAPY CESSATION 5 0.0001
396 OSTEOPOROSIS 4 0.0001
397 RIB FRACTURE 2 0.0001
398 SCRATCH 1 0.0001
399 INCONTINENCE 1 0.0001
400 BRONCHITIS 7 0.0001
401 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
402 CONTUSION 9 0.0001
403 MOVEMENT DISORDER 3 0.0001
404 HYPOACUSIS 4 0.0001
405 PHARYNGITIS STREPTOCOCCAL 1 0.0001
406 MENSTRUATION DELAYED 1 0.0001
407 CHRONIC KIDNEY DISEASE 7 0.0001
408 BIPOLAR DISORDER 1 0.0001
409 BACK INJURY 1 0.0001
410 PULMONARY THROMBOSIS 1 0.0001
411 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
412 GASTROINTESTINAL PAIN 1 0.0001
413 PERIPHERAL SWELLING 14 0.0001
414 MELAENA 2 0.0001
415 FOOT DEFORMITY 1 0.0001
416 DEHYDRATION 12 0.0001
417 SKIN INFECTION 1 0.0001
418 FISTULA 1 0.0001
419 BLOOD CALCIUM DECREASED 1 0.0001
420 STATUS EPILEPTICUS 1 0.0001
421 INTERNAL HAEMORRHAGE 1 0.0001
422 ILLNESS 9 0.0001
423 MEMORY IMPAIRMENT 12 0.0001
424 MUSCLE SPASMS 16 0.0001
425 MUSCLE TWITCHING 2 0.0001
426 DRY MOUTH 7 0.0001
427 HYPERHIDROSIS 11 0.0001
428 THYROID CANCER 1 0.0001
429 HYPOGLYCAEMIA 4 0.0001
430 PANIC ATTACK 3 0.0001
431 NEURALGIA 2 0.0001
432 BACK PAIN 19 0.0001
433 BALANCE DISORDER 7 0.0001
434 ABASIA 2 0.0001
435 CYST 1 0.0001
436 ILEUS 1 0.0001
437 DERMATITIS ALLERGIC 1 0.0001
438 INTRAOCULAR PRESSURE INCREASED 1 0.0001
439 HYPOPHAGIA 2 0.0001
440 ROTATOR CUFF SYNDROME 1 0.0001
441 ANOREXIA 1 0.0001
442 ANAPHYLACTIC SHOCK 2 0.0001
443 SKIN ULCER 2 0.0001
444 HIATUS HERNIA 1 0.0001
445 DIPLOPIA 2 0.0001
446 RESPIRATORY TRACT INFECTION 2 0.0001
447 PLATELET COUNT INCREASED 1 0.0001
448 NODULE 1 0.0001
449 JOINT STIFFNESS 2 0.0001
450 BEDRIDDEN 1 0.0001
451 DERMATITIS ATOPIC 4 0.0001
452 TOOTH INFECTION 1 0.0001
453 EAR INFECTION 2 0.0001
454 HAIR TEXTURE ABNORMAL 1 0.0001
455 MALIGNANT MELANOMA 1 0.0001
456 JOINT RANGE OF MOTION DECREASED 1 0.0001
457 FEAR 2 0.0001
458 COVID-19 13 0.0001
459 RASH PRURITIC 4 0.0001
460 IMPAIRED GASTRIC EMPTYING 1 0.0001
461 MIGRAINE 7 0.0001
462 PERIPHERAL COLDNESS 1 0.0001
463 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
464 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
465 HUNGER 1 0.0001
466 MASS 1 0.0001
467 ABDOMINAL DISCOMFORT 12 0.0001
468 CARPAL TUNNEL SYNDROME 1 0.0001
469 DEVICE OCCLUSION 1 0.0001
470 HEART RATE INCREASED 7 0.0001
471 DIALYSIS 1 0.0001
472 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
473 INTENTIONAL DOSE OMISSION 2 0.0001
474 HYPERSENSITIVITY 13 0.0001
475 PARALYSIS 1 0.0001
476 IMPAIRED QUALITY OF LIFE 1 0.0001
477 PARAESTHESIA ORAL 1 0.0001
478 FALL 23 0.0001
479 INTENTIONAL PRODUCT USE ISSUE 6 0.0001
480 DYSPHONIA 4 0.0001
481 BONE PAIN 4 0.0001
482 CHILLS 8 0.0001
483 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
484 COLON CANCER 1 0.0001
485 IMMUNODEFICIENCY 1 0.0001
486 ABDOMINAL DISTENSION 7 0.0001
487 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
488 THROAT IRRITATION 3 0.0001
489 BLOOD COUNT ABNORMAL 1 0.0001
490 STOMATITIS 4 0.0001
491 PLEURAL EFFUSION 4 0.0001
492 DRUG DISPENSING ERROR 1 0.0001
493 TINNITUS 3 0.0001
494 INJECTION SITE RASH 2 0.0001
495 LIMB DISCOMFORT 2 0.0001
496 PRODUCT DOSE OMISSION ISSUE 19 0.0001
497 TENDONITIS 1 0.0001
498 SOMNOLENCE 13 0.0001
499 LUNG INFECTION 1 0.0001
500 DIZZINESS 32 0.0001
501 THERAPY PARTIAL RESPONDER 1 0.0001
502 ASTHENIA 24 0.0001
503 INSOMNIA 17 0.0001
504 PRODUCT USE COMPLAINT 1 0.0001
505 FATIGUE 49 0.0001
506 ULCER 1 0.0001
507 HYPOTHYROIDISM 2 0.0001
508 MUSCULAR WEAKNESS 7 0.0001
509 BLOOD POTASSIUM INCREASED 1 0.0001
510 PRODUCT DOSE OMISSION 4 0.0001
511 PHOTOSENSITIVITY REACTION 1 0.0001
512 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
513 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
514 CYTOMEGALOVIRUS INFECTION 1 0.0001
515 COAGULOPATHY 1 0.0001
516 SKIN DISORDER 2 0.0001
517 NEOPLASM MALIGNANT 4 0.0001
518 GAIT INABILITY 2 0.0001
519 BLOOD UREA INCREASED 1 0.0001
520 PERICARDITIS 1 0.0001
521 TYPE 2 DIABETES MELLITUS 2 0.0001
522 FACE OEDEMA 1 0.0001
523 CANDIDA INFECTION 1 0.0001
524 HEMIPARESIS 1 0.0001
525 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
526 ACUTE KIDNEY INJURY 9 0.0001
527 METRORRHAGIA 1 0.0001
528 FEELING ABNORMAL 14 0.0001
529 SCAR 1 0.0001
530 MUSCULOSKELETAL DISCOMFORT 1 0.0001
531 NIGHTMARE 2 0.0001
532 LOCAL SWELLING 1 0.0001
533 MUSCULOSKELETAL PAIN 3 0.0001
534 DEVICE USE ISSUE 1 0.0001
535 PAIN 35 0.0001
536 LYMPHOCYTE COUNT DECREASED 1 0.0001
537 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
538 LYMPHADENOPATHY 2 0.0001
539 VISUAL IMPAIRMENT 7 0.0001
540 HEAD DISCOMFORT 1 0.0001
541 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 4 0.0001
542 CEREBRAL HAEMORRHAGE 2 0.0001
543 GASTROENTERITIS VIRAL 1 0.0001
544 ARTHRALGIA 23 0.0001
545 INFECTION 8 0.0001
546 LEUKOCYTOSIS 1 0.0001
547 RESTLESS LEGS SYNDROME 1 0.0001
548 TREATMENT NONCOMPLIANCE 3 0.0001
549 END STAGE RENAL DISEASE 1 0.0001
550 LOSS OF CONSCIOUSNESS 7 0.0001
551 AGITATION 4 0.0001
552 NAUSEA 43 0.0001
553 DIARRHOEA 35 0.0001
554 BLOOD GLUCOSE ABNORMAL 1 0.0001
555 HYPOAESTHESIA 8 0.0001
556 EYE PAIN 3 0.0001
557 DYSARTHRIA 2 0.0001
558 HALLUCINATION 4 0.0001
559 FOOT FRACTURE 1 0.0001
560 HEADACHE 33 0.0001
561 GASTRIC ULCER 1 0.0001
562 EYE IRRITATION 3 0.0001
563 LOWER LIMB FRACTURE 1 0.0001
564 DRUG PRESCRIBING ERROR 1 0.0001
565 ACUTE RESPIRATORY FAILURE 1 0.0001
566 GLAUCOMA 1 0.0001
567 HERNIA 1 0.0001
568 PRESCRIBED OVERDOSE 1 0.0001
569 ATRIAL FIBRILLATION 5 0.0001
570 PALPITATIONS 6 0.0001
571 ORAL HERPES 1 0.0001
572 SURGERY 3 0.0001
573 VISION BLURRED 7 0.0001
574 ARTHRITIS 4 0.0001
575 PARAESTHESIA 8 0.0001
576 ABNORMAL BEHAVIOUR 2 0.0001
577 COMPLICATION OF DEVICE INSERTION 1 0.0001
578 SPINAL FRACTURE 1 0.0000
579 PROSTATE CANCER 4 0.0000
580 PRODUCT PHYSICAL ISSUE 1 0.0000
581 TASTE DISORDER 1 0.0000
582 DISCOMFORT 3 0.0000
583 FEELING HOT 3 0.0000
584 HAEMOGLOBIN DECREASED 5 0.0000
585 LUNG NEOPLASM MALIGNANT 2 0.0000
586 INJECTION SITE WARMTH 1 0.0000
587 INFLUENZA LIKE ILLNESS 4 0.0000
588 TREMOR 8 0.0000
589 PRODUCT USE ISSUE 9 0.0000
590 BLOOD GLUCOSE INCREASED 9 0.0000
591 DERMATITIS 1 0.0000
592 RENAL IMPAIRMENT 4 0.0000
593 PAIN IN EXTREMITY 14 0.0000
594 MOUTH ULCERATION 1 0.0000
595 HALLUCINATION, VISUAL 1 0.0000
596 PLATELET COUNT DECREASED 5 0.0000
597 LIVER FUNCTION TEST INCREASED 1 0.0000
598 SKIN CANCER 1 0.0000
599 PRODUCT PRESCRIBING ISSUE 1 0.0000
600 ANXIETY 13 0.0000
601 RENAL FAILURE 6 0.0000
602 BLOOD PRESSURE DECREASED 3 0.0000
603 TOOTH DISORDER 1 0.0000
604 GLOSSODYNIA 1 0.0000
605 ADVERSE DRUG REACTION 4 0.0000
606 HEART RATE IRREGULAR 1 0.0000
607 PRODUCT AVAILABILITY ISSUE 1 0.0000
608 SKIN DISCOLOURATION 2 0.0000
609 CONFUSIONAL STATE 7 0.0000
610 SEIZURE 5 0.0000
611 BLOOD CHOLESTEROL INCREASED 2 0.0000
612 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
613 HYPERTENSION 9 0.0000
614 DRUG DOSE OMISSION 7 0.0000
615 NEUROPATHY PERIPHERAL 4 0.0000
616 DISEASE RECURRENCE 2 0.0000
617 RASH ERYTHEMATOUS 2 0.0000
618 MOBILITY DECREASED 3 0.0000
619 BLOOD PRESSURE FLUCTUATION 1 0.0000
620 BLOOD GLUCOSE DECREASED 2 0.0000
621 JOINT SWELLING 5 0.0000
622 MYALGIA 7 0.0000
623 FIBROMYALGIA 1 0.0000
624 ENCEPHALOPATHY 1 0.0000
625 VOMITING 19 0.0000
626 OSTEONECROSIS OF JAW 1 0.0000
627 DYSGEUSIA 3 0.0000
628 AGEUSIA 1 0.0000
629 DRY EYE 2 0.0000
630 CELLULITIS 2 0.0000
631 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
632 HAEMATEMESIS 1 0.0000
633 FLUID RETENTION 2 0.0000
634 PRURITUS 15 0.0000
635 ABDOMINAL PAIN UPPER 8 0.0000
636 MALAISE 17 0.0000
637 DECREASED APPETITE 9 0.0000
638 UNRESPONSIVE TO STIMULI 1 0.0000
639 RASH GENERALISED 1 0.0000
640 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
641 HAEMORRHAGE 4 0.0000
642 SPEECH DISORDER 2 0.0000
643 APPLICATION SITE ERYTHEMA 1 0.0000
644 GASTRITIS 1 0.0000
645 PANCREATITIS 2 0.0000
646 BRADYCARDIA 2 0.0000
647 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
648 PAIN OF SKIN 1 0.0000
649 PNEUMONITIS 1 0.0000
650 MOOD ALTERED 1 0.0000
651 GAIT DISTURBANCE 7 0.0000
652 DIVERTICULITIS 1 0.0000
653 PROCEDURAL PAIN 1 0.0000
654 MENTAL STATUS CHANGES 1 0.0000
655 INFLUENZA 4 0.0000
656 SEPSIS 4 0.0000
657 HAEMOPTYSIS 1 0.0000
658 NECK PAIN 2 0.0000
659 DEMENTIA 1 0.0000
660 BLISTER 2 0.0000
661 INCORRECT DRUG ADMINISTRATION DURATION 1 0.0000
662 HERPES ZOSTER 2 0.0000
663 PANCREATIC CARCINOMA 1 0.0000
664 RASH 15 0.0000
665 OFF LABEL USE 30 0.0000
666 NASAL CONGESTION 2 0.0000
667 PNEUMONIA 11 0.0000
668 BLADDER CANCER 2 0.0000
669 ACUTE MYOCARDIAL INFARCTION 1 0.0000
670 PSYCHOTIC DISORDER 1 0.0000
671 RESPIRATORY DISORDER 1 0.0000
672 IRRITABILITY 2 0.0000
673 CORONARY ARTERY DISEASE 1 0.0000
674 THERAPEUTIC RESPONSE DECREASED 2 0.0000
675 CONDITION AGGRAVATED 10 0.0000
676 OEDEMA PERIPHERAL 4 0.0000
677 VERTIGO 2 0.0000
678 EMOTIONAL DISORDER 1 0.0000
679 FEMUR FRACTURE 1 0.0000
680 SWELLING 3 0.0000
681 SWOLLEN TONGUE 1 0.0000
682 MOOD SWINGS 1 0.0000
683 HIP FRACTURE 1 0.0000
684 LACTIC ACIDOSIS 1 0.0000
685 DEPRESSION 7 0.0000
686 SWELLING FACE 2 0.0000
687 ALOPECIA 6 0.0000
688 CHOLELITHIASIS 1 0.0000
689 EYE DISORDER 1 0.0000
690 STAPHYLOCOCCAL INFECTION 1 0.0000
691 INFUSION RELATED REACTION 2 0.0000
692 VIRAL INFECTION 1 0.0000
693 EYE PRURITUS 1 0.0000
694 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
695 ANGER 1 0.0000
696 HEPATIC ENZYME INCREASED 2 0.0000
697 DELIRIUM 1 0.0000
698 NEOPLASM PROGRESSION 1 0.0000
699 HEART RATE DECREASED 1 0.0000
700 HYPOXIA 1 0.0000
701 PRODUCT USE IN UNAPPROVED INDICATION 7 0.0000
702 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
703 PRODUCT ADHESION ISSUE 1 0.0000
704 THERAPY INTERRUPTED 2 0.0000
705 INCORRECT ROUTE OF DRUG ADMINISTRATION 1 0.0000
706 ELECTROCARDIOGRAM QT PROLONGED 1 0.0000
707 DRUG EFFECT INCOMPLETE 1 0.0000
708 CRYING 1 0.0000
709 HYPERGLYCAEMIA 1 0.0000
710 RESPIRATORY FAILURE 2 0.0000
711 UNDERDOSE 2 0.0000
712 INJECTION SITE MASS 1 0.0000
713 EPISTAXIS 2 0.0000
714 RHEUMATOID ARTHRITIS 3 0.0000
715 DIABETES MELLITUS 2 0.0000
716 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
717 PYREXIA 9 0.0000
718 ABDOMINAL PAIN 6 0.0000
719 DISEASE PROGRESSION 3 0.0000
720 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
721 DISORIENTATION 1 0.0000
722 DRUG INTERACTION 4 0.0000
723 ABORTION SPONTANEOUS 1 0.0000
724 THROMBOSIS 2 0.0000
725 DYSPNOEA 14 0.0000
726 EXTRA DOSE ADMINISTERED 1 0.0000
727 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
728 PSORIATIC ARTHROPATHY 1 0.0000
729 DRUG INEFFECTIVE 32 0.0000
730 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
731 ROAD TRAFFIC ACCIDENT 1 0.0000
732 OSTEOARTHRITIS 1 0.0000
733 RECTAL HAEMORRHAGE 1 0.0000
734 MENTAL DISORDER 1 0.0000
735 PRODUCT STORAGE ERROR 2 0.0000
736 MUSCULOSKELETAL STIFFNESS 2 0.0000
737 COLITIS ULCERATIVE 1 0.0000
738 PULMONARY OEDEMA 1 0.0000
739 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
740 THERAPY NON-RESPONDER 1 0.0000
741 NASOPHARYNGITIS 4 0.0000
742 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
743 OROPHARYNGEAL PAIN 2 0.0000
744 CHEST PAIN 4 0.0000
745 RENAL DISORDER 1 0.0000
746 BREAST CANCER 2 0.0000
747 COUGH 6 0.0000
748 ANAEMIA 4 0.0000
749 MULTIPLE SCLEROSIS 1 0.0000
750 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
751 DRUG INTOLERANCE 2 0.0000
752 LUNG DISORDER 1 0.0000
753 SYNCOPE 2 0.0000
754 AGGRESSION 1 0.0000
755 FLUSHING 2 0.0000
756 CHEST DISCOMFORT 2 0.0000
757 INFLAMMATION 1 0.0000
758 NERVOUSNESS 1 0.0000
759 ECZEMA 1 0.0000
760 DEPRESSED MOOD 1 0.0000
761 DRUG EFFECT DECREASED 1 0.0000
762 DISTURBANCE IN ATTENTION 1 0.0000
763 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
764 HAEMATOCHEZIA 1 0.0000
765 ANAPHYLACTIC REACTION 1 0.0000
766 ARTHROPATHY 1 0.0000
767 MEDICATION ERROR 1 0.0000
768 WEIGHT DECREASED 5 0.0000
769 URTICARIA 3 0.0000
770 WEIGHT INCREASED 4 0.0000
771 INCORRECT DOSE ADMINISTERED 4 0.0000
772 LETHARGY 1 0.0000
773 PRODUCT SUBSTITUTION ISSUE 1 0.0000
774 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
775 WHEEZING 1 0.0000
776 CATARACT 1 0.0000
777 SUICIDE ATTEMPT 1 0.0000
778 ILL-DEFINED DISORDER 1 0.0000
779 INJECTION SITE PAIN 5 0.0000
780 DEEP VEIN THROMBOSIS 1 0.0000
781 AMNESIA 1 0.0000
782 BLOOD CREATININE INCREASED 1 0.0000
783 DRY SKIN 2 0.0000
784 HYPOTENSION 3 0.0000
785 INJECTION SITE PRURITUS 1 0.0000
786 PRODUCT QUALITY ISSUE 2 0.0000
787 NEUTROPENIA 2 0.0000
788 ERYTHEMA 3 0.0000
789 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
790 INJECTION SITE REACTION 1 0.0000
791 INJURY 1 0.0000
792 SKIN BURNING SENSATION 1 0.0000
793 UNEVALUABLE EVENT 1 0.0000
794 HOSPITALISATION 2 0.0000
795 INJECTION SITE BRUISING 1 0.0000
796 INJECTION SITE HAEMORRHAGE 1 0.0000
797 CARDIAC FAILURE 1 0.0000
798 CARDIAC FAILURE CONGESTIVE 1 0.0000
799 COMPLETED SUICIDE 1 0.0000
800 TOXICITY TO VARIOUS AGENTS 2 0.0000
801 SKIN EXFOLIATION 1 0.0000
802 CEREBROVASCULAR ACCIDENT 2 0.0000
803 DEATH 10 0.0000
804 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
805 SUICIDAL IDEATION 1 0.0000
806 CARDIAC DISORDER 1 0.0000
807 DYSPHAGIA 1 0.0000
808 THROMBOCYTOPENIA 1 0.0000
809 INJECTION SITE ERYTHEMA 1 0.0000
810 NO ADVERSE EVENT 1 0.0000
811 OVERDOSE 1 0.0000